← Leaderboards
Bruce Liang
Cornovus Pharmaceuticals, Inc.
$2,477,183
Attributed
$2,477,183
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,477,183 · 2
By mechanism
R42$2,043,700 · 1
R41$433,483 · 1
Top collaborators
No co-investigators on record.
Most similar at Cornovus Pharmaceuticals, Inc.
Same institution · by research overlap
- Terence Kelly$968,717
- R Mark Van Allen$1,018,717
Others in their field
Other Emerging Leaders on “In Vivo”
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,216,744
- Leonard Freedmand · Leidos Biomedical Research, Inc.$66,248,714
- John Damon Chodera · Sloan-Kettering Inst Can Research$43,427,103
- Tony Moody · Duke University$34,777,314
- Alan D. Palkowitz · Indiana University Indianapolis$18,925,366
Research focus
In VivoLaboratory ResearchExperimental StudyInsightKidney DiseasesLaboratoriesChemistryEndovascular ThrombectomyImmuneInflammatoryDiabetes MellitusIschemic StrokeDoseDigestive System DisordersAcuteCellsAnti-Inflammatory AgentsConnecticutCollaborationsGrantInfarctionInflammationAlteplaseLead